Boron tribromide → Vatalanib metabolite M26
반응식
B(Br)(Br)Br.[Cl:5][C:6]1[CH:29]=[CH:28][C:9]([NH:10][C:11]2[C:20]3[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=3)[C:14]([CH2:21][C:22]3[CH:27]=[CH:26][N:25]=[CH:24][CH:23]=3)=[N:13][N:12]=2)=[CH:8][C:7]=1[O:30]C>ClCCl>[Cl:5][C:6]1[CH:29]=[CH:28][C:9]([NH:10][C:11]2[C:20]3[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=3)[C:14]([CH2:21][C:22]3[CH:27]=[CH:26][N:25]=[CH:24][CH:23]=3)=[N:13][N:12]=2)=[CH:8][C:7]=1[OH:30]참가 물질
실험 절차
A solution of 2 ml boron tribromide (≈1M in CH2Cl2) is mixed with a suspension of 0.19 g (0.50 mmol) 1-(4-chloro-3-methoxyanilino)-4-(4-pyridylmethyl)phthalazine (Example 68B) in 4 ml dichloromethane at 0° C. under a nitrogen atmosphere. The resinous mixture is left to stand for 18 h at RT, the dichloromethane phase is then decanted, and the glutinous residue stirred with 10 ml THF and 5 ml sat. NaHCO3 solution. The resulting suspension is filtered, the filter residue washed with THF and discarded. The THF phase is separated and dried (Na2SO4), concentrated by evaporation, chromatographed (SiO2; acetate/CH3OH, 40:1→19:1) and title compound crystallized from acetonitrile/methanol: m.p.: 245-246° C.; HPLC: tRet(Grad5-40)=8.8; FAB MS (M+H)+=363.
후처리
- waitThe resinous mixture is left
- customthe dichloromethane phase is then decanted
- filtrationThe resulting suspension is filtered
- washthe filter residue washed with THF
- customThe THF phase is separated
- dry with materialdried (Na2SO4)
- concentrationconcentrated by evaporation
- customchromatographed (SiO2; acetate/CH3OH, 40:1→19:1) and title compound
- customcrystallized from acetonitrile/methanol
출처 및 근거
- ORD 기록
- ord-752133b08fb24a7295af5f5b55e78ce9
- 출처 데이터셋
- uspto-grants-2004_03
- 특허 번호
- US06710047B2
반응 노트
불러오는 중…